BRD4
“BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19)”. The American Journal of Pathology 159 (6): 1987–92. (Dec 2001). doi:10.1016/S0002-9440(10)63049-0. PMC 1850578. PMID 11733348. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1850578/.
“A Mammalian bromodomain protein, brd4, interacts with replication factor C and inhibits progression to S phase”. Molecular and Cellular Biology 22 (18): 6509–20. (Sep 2002). doi:10.1128/MCB.22.18.6509-6520.2002. PMC 135621. PMID 12192049. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC135621/.
“BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma”. Cancer Research 63 (2): 304–7. (Jan 2003). PMID 12543779.
Journal of Medical Genetics 42 (7): 558–64. (Jul 2005). doi:10.1136/jmg.2004.029686. PMC 1736105. PMID 15994877. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1736105/.
“Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function”. Journal of Virology 80 (9): 4276–85. (May 2006). doi:10.1128/JVI.80.9.4276-4285.2006. PMC 1472042. PMID 16611886. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1472042/.
“Brd4 links chromatin targeting to HPV transcriptional silencing”. Genes & Development 20 (17): 2383–96. (Sep 2006). doi:10.1101/gad.1448206. PMC 1560413. PMID 16921027. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1560413/.